The global VR market to grow at a compound annual growth rate of 13% from $7 billion in 2018 to $28 billion in 2030.
Quinten Health will announce in the coming months strategic partnerships with big pharma companies and data owners to launch the first disease modeling platforms.
Sanjay Verma of Akums Drugs & Pharmaceuticals, Manu Gupta of Cadila Pharmaceuticals, Rahul Borse of RPG Life Sciences, Krishna Sai T of Biocon and Amit Saluja of NASSCOM are speakers
Agreement to co-develop artificial intelligence (AI) technology for the application in peptide drug design
Large datasets will train machine learning models and speed up agile discovery of novel crop protection solutions
The innovative software module is designed to meet growing scientific demand from researchers and drug developers
C2i Genomics expands its global reach and brings the first whole-genome sequencing minimal residual disease test to India
PharmaLytica Expo to aid in chalking out pharma industry’s $130 Billion growth story by 2030
Besides enhancing workflow operations by connecting scientists with their lab instruments and data, digitalization holds the potential to acceleratee long-term business growth
The partnership aims to enhance HotSpot's drug discovery and development efforts by incorporating GOSTAR's high-quality, annotated datasets into HotSpot's machine learning (ML) and artificial intelligence (AI) models
Subscribe To Our Newsletter & Stay Updated
